Bio-Rad BioPlex 2200 Anti-CCP test
Bio-Rad Laboratories and Axis-Shield have launched Bio-Rad’s BioPlex 2200 Anti-CCP test for the early detection of rheumatoid arthritis. The assay, which will run on Bio-Rad’s BioPlex 2200 system, measures anti-CCP (anti-cyclic citrullinated peptide antibodies), a novel marker that has been shown to have superior specificity in the diagnosis of rheumatoid arthritis. The BioPlex 2200 Anti-CCP kit is based on Axis-Shield’s proprietary anti-CCP technology. The assay is available for sale in certain countries outside the US.
The BioPlex 2200 system is a fully automated, random-access multiplex testing platform with an assay menu targeting autoimmune diagnostics and infectious diseases. In the US, the BioPlex 2200 Anti-CCP kit is pending clearance by the FDA.
Phone: 02 9914 2800
Takara Bio PrimeCap T7 RNA Polymerase (low dsRNA)
The polymerase is designed to remove both the technical and financial barriers to the successful...
Maxwell Biosystems MaxTwo high-density microelectrode array (HD-MEA) system
The next-generation multiwell HD-MEA captures high-quality signals at subcellular resolution from...
Enzo Life Sciences PROTEOSTAT Protein refolding and aggregation sensing kit
The kit includes a comprehensive set of optimised screening reagents and conditions that...
